Company Filing History:

14 out of 2,882

The General Hospital Corporation

patents

5 out of 3,681

Bristol-myers Squibb Compnay

patents

1 out of 83

Massachusetts General Hospital Corporation

where one patent can have more than one assignee

Years Active: 1982-2007

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7189829 - Baboon TAFI polypeptides (2007-03-13),

2. 7091331 - Nucleic acid molecules and polypeptides encoding baboon TAFI (2006-08-15),

3. 6576431 - Antibodies that bind to &agr;2-antiplasmin crosslinked to fibrin which do not inhibit plasma &agr;2-antiplasmin (2003-06-10),

4. 6280730 - Antibodies that bind to &agr;2-antiplasmin crosslinked to fibrin which do not inhibit plasma &agr;2-antiplasmin (2001-08-28),

5. 6114506 - Composition and method for enhancing fibrinolysis (2000-09-05),

6. 5831031 - Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which (1998-11-03),

7. 5773228 - Activation-dependent protein expressed on the surface of activated (1998-06-30),

8. 5620688 - Methods of inhibiting the activation of Factor XIII (1997-04-15),

9. 5582862 - Antibodies that bind to .alpha.2-antiplasmin crosslinked to fibrin which (1996-12-10),

10. 5571708 - Thrombin-activatable plasminogen activator (1996-11-05),

11. 5446132 - Thrombin-activated platelet protein-2 (TAPP-2) (1995-08-29),

12. 5372812 - Composition and method for acceleration of clot lysis (1994-12-13),

13. 5357042 - Synthetic peptides capable of eliciting fibrin-specific monoclonal (1994-10-18),

14. 5256413 - Method and use for site-specific activation of substances (1993-10-26),

15. 5116613 - Antibody-thrombolytic agent product and method of use (1992-05-26),

Title: Gary R Matsueda: Innovator in Blood Clotting Research

Introduction

Gary R Matsueda is a prominent inventor based in Princeton, NJ (US). He has made significant contributions to the field of blood clotting research, holding a total of 18 patents. His work focuses on the development of novel therapeutic agents that can regulate blood clotting, which is crucial for treating various blood disorders.

Latest Patents

One of Matsueda's latest patents involves the isolation and identification of novel baboon thrombin-activatable fibrinolysis inhibitors, known as TAFI. This invention relates to the discovery of baboon nucleic acid molecules and the proteins and polypeptides they encode. The novel baboon TAFI proteins and polypeptides inhibit the breakdown of blood clots, making them potentially useful for treating conditions such as hemophilia and von Willebrand's disease. Additionally, these sequences can be utilized in screening methods to identify compounds that modulate the expression of baboon TAFI nucleic acids and their activity. Such compounds may serve as agonists or antagonists in the treatment of various thrombotic diseases, including deep venous thrombosis and coronary artery disease.

Career Highlights

Throughout his career, Gary R Matsueda has worked with notable organizations, including The General Hospital Corporation and Bristol-Myers Squibb Company. His innovative research has led to advancements in understanding blood clotting mechanisms and developing therapeutic solutions.

Collaborations

Matsueda has collaborated with esteemed colleagues such as Edgar Haber and Guy L Reed, contributing to the advancement of research in his field.

Conclusion

Gary R Matsueda's contributions to blood clotting research and his innovative patents highlight his role as a key inventor in the medical field. His work continues to pave the way for new treatments that can improve the lives of individuals with blood disorders.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.